Tuesday 14 February 2017

MedGenome Improving Health Status by High-End Genomic Research and Diagnostics

The immune system of the human physiology can differ between the normal and foreign cells. To evoke a particular immune response, a ‘checkpoint’ site on the immune cells needs to be activated or deactivated so that the cells can distinguish between normal and foreign cells. The cancer cells have the capability to bypass the detection process of the immune system by using the checkpoints on the immune cells. MedGenome is the best genomics lab where appropriate genetic information of Checkpoint control inhibitors in cancer is provided via decoding techniques.

Immunology-based Therapeutic Treatment

One of the best ways to tackle and cure cancer is to find the proper genetic sequence from the samples of the subject. The foreign or cancer cells often use the ‘immune checkpoints’ to inhibit the regulatory pathways and grow in a rampant way.

Our accurate test and sequencing methods will enable our clients to find out the right approach to cure a particular disease. The tests offered are enlisted below to detect the Checkpoint control inhibitors in cancer.


  • NGS (Next Generation Sequencing)
  • MLPA (Multiplex Ligation-dependent Probe Amplification)
  • IHC (Immunohistochemistry)
  • Sanger (Sanger Sequencing)
  • Real-Time PCR

Use of TCR Sequencing

T-cell receptor (TCR) aids the immune system to detect the difference between the normal and abnormal cells for proper physiological actions. TCR Sequencing techniques, which are the latest in the research and development field of the genetic sequencing, are used for apt development of biomarkers and respective diagnostics for different immunological and neoplastic diseases.

To unravel the basis of cancer, hereditary diseases, neurological disorders and other rare diseases in the genetic level, TCR Sequencing is used with cutting edge methods and high-level bioinformatics.

Advantages with us

MedGenome offers superior solutions for genetic sequencing and bioinformatics around the globe. The proficient team of diverse expertise is working in the South Asian continent since 2013 and has been building a strong presence in North America as well. The fully functioning units in California are ready to handle operations in US and can contribute to working for the betterment of global health through genomics based research.